Proliferative inhibition, cell-cycle dysregulation, and induction of apoptosis by ursolic acid in human non-small cell lung cancer A549 cells
- 20 August 2004
- journal article
- Published by Elsevier in Life Sciences
- Vol. 75 (19) , 2303-2316
- https://doi.org/10.1016/j.lfs.2004.04.027
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Bcl-2 Down-Regulation Is a Novel Mechanism of Paclitaxel ResistanceMolecular Pharmacology, 2003
- NF-κB SignalingCell, 2002
- Cellular stress response and apoptosis in cancer therapyBlood, 2001
- Apoptosis induced in HepG2 cells by short exposure to millimolar concentrations of ethanol involves the Fas-receptor pathwayZeitschrift für Krebsforschung und Klinische Onkologie, 2001
- Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agentsBiochemical Pharmacology, 2000
- The Bcl-2 Protein FamilyExperimental Cell Research, 2000
- Ursolic acid-induced down-regulation of MMP-9 gene is mediated through the nuclear translocation of glucocorticoid receptor in HT1080 human fibrosarcoma cellsOncogene, 1998
- Intracellular Ca2+ release mediates ursolic acid–induced apoptosis in human leukemic HL-60 cellsInternational Journal of Cancer, 1997
- Inhibitory effect of ursolic acid on B16 proliferation through cell cycle arrestCancer Letters, 1996
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992